Capricor Therapeutics Announces 24-Month HOPE-3 Data On Deramiocel In Duchenne Muscular Dystrophy To Be Presented At World Muscle Society Congress September 29 To October 3

Benzinga Newsdesk www.benzinga.com Neutral 84.4%

Neg 0% Neu 84.4% Pos 0%

Comments

No comments yet. Be the first!